Accelerating the Drug Releasing Performance by Flexible Zinc-Air Fuel Cell based on Polyacrylamide/Cellulose Nanofibril (PAM/CNF) Hydrogel
Sign Up to like & getrecommendations! Published in 2025 at "Journal of Materials Chemistry A"
DOI: 10.1039/d4ta06566b
Abstract: With the merits of non-toxic, biocompatible and non-sensitizing, hydrogel wound dressings are considered as the one of the promising choices to prevent wound infection and accommodate the healing drugs. However,... read more here.
Keywords: releasing performance; hydrogel; drug releasing; flexible zinc ... See more keywords
Nanodrug delivery materials for digestive system diseases
Sign Up to like & getrecommendations! Published in 2024 at "APL Materials"
DOI: 10.1063/5.0214020
Abstract: Digestive system diseases, such as gastritis, gastric ulcers, chronic liver disease, inflammatory bowel disease (IBD), and colorectal cancer, represent a major group of diseases that have high morbidity and death rates worldwide. Their incidence continues… read more here.
Keywords: system diseases; drug releasing; delivery; releasing materials ... See more keywords
Drug-releasing intravesical floating technology for sequential gemcitabine and docetaxel in non-muscle-invasive bladder cancer.
Sign Up to like & getrecommendations! Published in 2025 at "BJU international"
DOI: 10.1111/bju.70060
Abstract: To develop a drug‐releasing intravesical floating technology (DRIFT) device for controlled sequential delivery of gemcitabine and docetaxel (Gem/Doce) to optimise the treatment of non‐muscle‐invasive bladder cancer (NMIBC) while enabling patient mobility and self‐removal, as sequential… read more here.
Keywords: intravesical floating; releasing intravesical; drug releasing; gemcitabine docetaxel ... See more keywords
Abstract LB290: Intracranial, intratumoral drug-releasing microdevices in patients with high grade gliomas may identify biomarkers of drug activity and predict tumor response to systemic chemotherapy
Sign Up to like & getrecommendations! Published in 2023 at "Cancer Research"
DOI: 10.1158/1538-7445.am2023-lb290
Abstract: The lack of reliable predictive biomarkers to guide effective therapy is a major obstacle for the advancement of therapy for high grade gliomas (HGG), and particularly glioblastoma (GBM), one of the few cancers whose prognosis… read more here.
Keywords: response; high grade; grade gliomas; drug releasing ... See more keywords